Evidence map›Paper›PMID 33709269›Full record

ArticleCardiovascular and interventional radiology2021

The Addition of Lipid-Based Contrast Medium does not Inactivate the Detergent Sclerosant Sodium Tetradecyl Sulfate in-vitro.

Charlotte L Oliver, Judy Brown, Mike Watkins, Ian McCafferty, Richard J Oliver

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular and interventional radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Charlotte L OliverLimbco Ltd, Plough Lane, Hereford, HR4 0EL, UK.ORCID https://orcid.org/0000-0002-4722-6934
Judy BrownLimbco Ltd, Plough Lane, Hereford, HR4 0EL, UK.
Mike WatkinsLimbco Ltd, Plough Lane, Hereford, HR4 0EL, UK.
Ian McCaffertyQueen Elizabeth Hospital Birmingham, Birmingham, UK.
Richard J OliverLimbco Ltd, Plough Lane, Hereford, HR4 0EL, UK. roliver@limbco.uk.ORCID https://orcid.org/0000-0002-0907-1388
Wye Valley NHS Trust · GBQueen Elizabeth Hospital Birmingham · GBSerco (United Kingdom) · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate if the detergent sclerosant sodium tetradecyl sulfate (STS) is deactivated by the lipid-based contrast agent ethiodised oil.

method3% STS was mixed with ethiodised oil and room air in a 2:1:4 ratio in two luer lock syringes and a three way connector and agitated to make foam (the Tessari technique) to replicate the clinical use of the products. The assay of STS in the mixture was assessed using the British Pharmacopoeia method. Briefly this is a manual titration method where the solution of STS is mixed with an indicator solution and titrated with hyamine solution of known concentration; the concentration of the STS can then be calculated with the titration results. To further mimic the clinical environment with the presence of blood, the effect of adding increasing amounts of albumin to the STS-ethiodised oil mixture was assessed.

resultsThe assay of STS in the solution after mixing with ethiodised oil was 3% indicating that the ethiodised oil did not deactivate the STS. The addition of albumin to the STS-contrast mixture resulted in near linear neutralisation of the STS with increasing concentrations in the same quantities as with STS alone.

conclusionsThe mixture of the lipid-based contrast agent ethiodised oil with the detergent sclerosant STS did not affect the availability of the sclerosant. The continued use of STS-ethiodised oil in the management of vascular malformations can be supported.

Indexed as

Contrast MediaEthiodized OilHumansSclerosing SolutionsSclerotherapySodium Tetradecyl SulfateSyringesVascular MalformationsContrast MediaEthiodized OilSclerosing SolutionsSodium Tetradecyl SulfateArteriovenous malformationsLymphatic malformationsSclerotherapySodium tetradecyl sulfateVascular malformationsVenous malformations

Identifiers

PMID33709269
OpenAlexW3134442749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.